Virtual Conference

Track: Cancer Nanotechnology  

Cancer Nanotechnology  

Sub-Track:

In cancer treatment, nanotechnology has revolutionized drug delivery systems. Nanoparticles can encapsulate and transport anti-cancer drugs, allowing for targeted delivery to the tumor site while minimizing exposure to healthy tissues. This targeted drug delivery system improves treatment efficacy, reduces side effects, and enhances patient outcomes. Additionally, nanoparticles can deliver therapeutic agents, such as RNA interference molecules or gene therapies, directly into cancer cells, offering new avenues for personalized and precise cancer treatments. Moreover, nanotechnology plays a significant role in enhancing the effectiveness of radiation therapy. Nanoparticles can be designed to enhance the absorption of radiation in tumors, leading to increased tumor destruction while sparing healthy tissues. These radiation-enhancing nanoparticles, known as radiosensitizers, have the potential to improve the outcomes of radiation therapy and overcome treatment resistance. In cancer research, nanotechnology provides valuable tools for studying the biology of cancer cells and understanding disease mechanisms at the nanoscale level. Nanosensors and nanodevices enable real-time monitoring of biomarkers, tumor microenvironment, and drug responses, contributing to the development of personalized and precision medicine approaches.

The field of cancer nanotechnology is a dynamic area of research, with ongoing studies focusing on improving the design and functionality of nanoparticles, exploring novel therapeutic strategies, and addressing challenges related to scalability, regulatory approval, and safety considerations. Overall, cancer nanotechnology research holds great promise for advancing cancer care by providing innovative approaches for early detection, targeted therapy, and improved treatment outcomes. Continued advancements in this field have the potential to revolutionize cancer diagnosis and treatment, leading to better patient outcomes and enhanced quality of life.

SUBTOPICS:
·        Delivering Chemotherapy
·        Nano-enabled Immunotherapy
·        Delivering or Augmenting Radiotherapy
·        Delivering Gene Therapy